Niva Bupa Health Insurance Company Ltd (NIVABUPA) Q1 FY27 Results Analysis: PAT Nearly Doubles, Combined Ratio Improves 495 bps

Niva Bupa Health Insurance Company Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 2,273.72 Cr (+28.56% YoY) and PAT growth of +92.89% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

NIVABUPA delivered a strong Q1 FY27 with 28.6% revenue growth and PAT nearly doubling, driven by a 495 bps improvement in combined ratio to 93.55%. The health segment remains the core driver with expanding margins. However, a declining solvency ratio and pending regulatory forbearance on EOM exceedance are key risks to monitor.

Key Investment Insights

Key Positives

• Insurance Revenue grew 28.6% YoY to Rs.2,273.72 Cr, well above industry CAGR of 17-19%.
• Combined Operating Ratio improved to 93.55% from 98.50% YoY, a 495 bps improvement.
• PAT nearly doubled YoY to Rs.137.80 Cr, a 92.9% increase.
• Claims ratio improved to 63.01% from 66.83% YoY.
• Expense ratio improved to 30.54% from 31.67% YoY.
• Health segment revenue grew 28.44% YoY with profit up 93%.
• No exceptional items; reported PAT is normalized.

Risk Factors

• Solvency ratio declined to 2.25x from 2.86x YoY and 2.49x QoQ, requiring monitoring.
• Travel segment reported a small loss of Rs.0.29 Cr.
• EOM ratio at 35.15% is near the cap of 36.24% (including allowances); FY25 forbearance still pending.
• Contingent liability of Rs.12,716 lakhs for income tax demands (AY2020-21 to AY2023-24).
• Auditor's Emphasis of Matter on pending EOM exceedance forbearance.